Targeting CMTM6 to modulate cell surface PD-L1 expression and antitumour immune responses

被引：0
|
作者：
Burr, Marian L. [1 ,2 ,3 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[3] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IS7-4
引用
收藏
页码：623 / 623
页数：1
相关论文
共 50 条
  • [21] CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
    Burr, Marian L.
    Sparbier, Christina E.
    Chan, Yih-Chih
    Williamson, James C.
    Woods, Katherine
    Beavis, Paul A.
    Lam, Enid Y. N.
    Henderson, Melissa A.
    Bell, Charles C.
    Stolzenburg, Sabine
    Gilan, Omer
    Bloor, Stuart
    Noori, Tahereh
    Morgens, David W.
    Bassik, Michael C.
    Neeson, Paul J.
    Behren, Andreas
    Darcy, Phillip K.
    Dawson, Sarah-Jane
    Voskoboinik, Ilia
    Trapani, Joseph A.
    Cebon, Jonathan
    Lehner, Paul J.
    Dawson, Mark A.
    NATURE, 2017, 549 (7670) : 101 - 105
  • [22] CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors
    Mamessier, Emilie
    Birnbaum, David J.
    Finetti, Pascal
    Birnbaum, Daniel
    Bertucci, Francois
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (03)
  • [23] The predictive value and correlation of β-catenin, CMTM6, and PD-L1 expression in colorectal cancer
    Li, Bingquan
    Wu, Shigang
    Qiu, Zhanlong
    Zhong, Xuejun
    Chen, Zhe
    Luo, Feng
    Li, Jinbang
    Liu, Kunping
    NEOPLASMA, 2022, 69 (03) : 691 - 699
  • [24] CMTM6 status predicts survival in head and neck squamous cell carcinoma and correlates with PD-L1 expression
    Anne-Sophie Becker
    Nicolas Wieder
    Sarah Zonnur
    Annette Zimpfer
    Mareike Krause
    Björn Schneider
    Daniel Fabian Strüder
    Ann-Sophie Burmeister
    Andreas Erbersdobler
    Christian Junghanss
    Claudia Maletzki
    Discover Oncology, 15 (1)
  • [25] CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma
    Yugawa, Kyohei
    Itoh, Shinji
    Yoshizumi, Tomoharu
    Iseda, Norifumi
    Tomiyama, Takahiro
    Morinaga, Akinari
    Toshima, Takeo
    Harada, Noboru
    Kohashi, Kenichi
    Oda, Yoshinao
    Mori, Masaki
    HEPATOLOGY COMMUNICATIONS, 2021, 5 (02) : 334 - 348
  • [26] WNT/β-catenin Signaling Pathway Regulating PD-L1 Expression by CMTM6 in Colorectal Cancer
    Liu, Kunping
    Li, Jinbang
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 711 - 711
  • [27] HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer
    Liu, Yanbin
    Li, Xingzhi
    Zhang, Hui
    Zhang, Mingming
    Wei, Yanli
    ONCOGENE, 2021, 40 (12) : 2230 - 2242
  • [28] The association of CMTM6 expression with prognosis and PD-L1 expression in triple-negative breast cancer
    Tian, Yiping
    Sun, Xiaohui
    Cheng, Guoping
    Ji, Enming
    Yang, Shifeng
    Feng, Jianguo
    Zheng, Linfeng
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (02)
  • [29] HuR up-regulates cell surface PD-L1 via stabilizing CMTM6 transcript in cancer
    Yanbin Liu
    Xingzhi Li
    Hui Zhang
    Mingming Zhang
    Yanli Wei
    Oncogene, 2021, 40 : 2230 - 2242
  • [30] WNT/β-catenin Signaling Pathway Regulating PD-L1 Expression by CMTM6 in Colorectal Cancer
    Liu, Kunping
    Li, Jinbang
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 711 - 711
12345